About: The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic
Creator	Shah, Ajay Bromage, Daniel Mcdonagh, Theresa Cannata, Antonio Gregorio, Caterina Piper, Susan Rind, Irfan
source	Medline; PMC
abstract	AIMS: To examine the impact of COVID‐19 on acute heart failure (AHF) hospitalization rates, clinical characteristics and management of patients admitted to a tertiary Heart Failure Unit in London during the peak of the pandemic. METHODS AND RESULTS: Data from King's College Hospital, London, reported to the National Heart Failure Audit for England and Wales, between 2nd March – 19(th) April 2020 were compared both to a pre‐COVID cohort and the corresponding time periods in 2017‐2019 with respect to absolute hospitalization rates. Furthermore, we performed detailed comparison of patients hospitalized during the COVID‐19 pandemic and patients presenting in the same period in 2019 with respect to clinical characteristics and management during the index admission. A significantly lower admission rate for AHF was observed during the study period compared to all other included time periods. Patients admitted during the COVID‐19 pandemic had higher rates of NYHA III or IV symptoms (96% vs. 77%, p=0.03) and severe peripheral oedema (39% vs. 14%, p=0.01). We did not observe any differences in inpatient management, including place of care and pharmacological management of heart failure with reduced ejection fraction (HFrEF) CONCLUSION: Incident AHF hospitalization significantly declined in our centre during the COVID‐19 pandemic, but hospitalized patients had more severe symptoms at admission. Further studies are needed to investigate whether the incidence of AHF declined or patients did not present to hospital while the national lockdown and social distancing restrictions were in place. From a public health perspective, it is imperative to ascertain whether this will be associated with worse long‐term outcomes. This article is protected by copyright. All rights reserved.
has issue date	2020-06-01(xsd:dateTime)
bibo:doi	10.1002/ejhf.1925
bibo:pmid	32478951
has license	no-cc
sha1sum (hex)	f0e02bc4b042d9da15b84297e18866dd2e3ba7c0
schema:url	https://doi.org/10.1002/ejhf.1925
resource representing a document's title	The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic
has PubMed Central identifier	PMC7300902
has PubMed identifier	32478951
schema:publication	Eur J Heart Fail
resource representing a document's body	covid:f0e02bc4b042d9da15b84297e18866dd2e3ba7c0#body_text
is schema:about of	named entity 'Heart Failure' named entity 'impact' named entity 'COVID-19 pandemic' named entity 'AHF' named entity 'COVID-19' named entity 'multiple comparisons' named entity 'AHF' named entity 'ACS' named entity 'inpatient and outpatient' named entity 'AHF' named entity 'COVID-19 in the UK' named entity 'King's College Hospital' named entity 'mortality rates' named entity 'AHF' named entity 'comorbidity' named entity 'NYHA class' named entity 'healthcare systems' named entity 'SPSS' named entity 'England and Wales' named entity 'electronic referral' named entity 'Demographic' named entity 'residual confounding' named entity 'interquartile range' named entity 'medical conditions' named entity 'heart failure' named entity 'life-threatening' named entity 'AHF' named entity 'relative risk' named entity 'COVID-19' named entity 'NYHA' named entity 'primary care' named entity 'ACS' named entity 'one-way ANOVA' named entity 'general medical' named entity 'follow-up' named entity 'social distancing' named entity 'optimal medical therapy' named entity 'AHF' named entity 'COVID-19 pandemic' named entity 'heart failure' named entity 'AHF' named entity 'follow-up' named entity 'follow-up' named entity 'COVID-19' named entity 'COVID-19' named entity 'Heart Failure' named entity 'Heart Failure' named entity 'March 2020' named entity 'ICD codes' named entity 'AHF' named entity 'Stata' named entity 'respiratory illness' named entity 'COVID-19 pandemic' named entity 'peripheral oedema' named entity 'AHF' named entity 'relative risk' named entity 'Heart Failure' named entity 'AHF' named entity 'COVID-19 pandemic' named entity 'infection' named entity '1, 2' named entity 'COVID-19' named entity 'pharmacological' named entity 'NYHA class' named entity 'follow-up' named entity 'public health' named entity 'Incidence rates' named entity 'general medical' named entity 'evidence-based' named entity 'diagnostic tests' named entity 'standard deviation' named entity '3, 4' named entity 'diuretic' named entity 'nurse education' named entity 'AHF'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software